Taureau
Administrator
Ostarine, which is also known as Ostabolic or MK2866, is a selective androgen receptor modulator (SARM). At the present time, it is still in the clinical testing phase, where it has been found to positively influence muscle mass and bone health. What's more, it has also proven itself to be effective in the treatment of age related muscle wasting issues, as well as with prevention of muscle wasting in those with cancer and other diseases. Therefore, it is not surprising that this compound is currently one of the most popularly used SARMS in the fitness world.
History
Originally, ostarine was under development by Merck, and has since been taken over by GTX, Inc. The end goal of developing mk2866 is to replace growth hormone and hormone replacement therapy, especially with those suffering from old age or muscle wasting diseases.
In the meantime, athletes have acquired ostabolic, and have utilized it to help them reach their fitness goals. Hence the reason it has become extremely widespread in the crossfit community in recent years.
How it Works
Ostabolic does what all SARMS do - it binds and activates the androgen receptors to create a boost in protein synthesis, making muscle and strength gains much easier for the user, and preventing any sort of catabolic effects. Nonetheless, unlike anabolic steroids, it does this without causing prostate issues and shutdown of the pituitary glands. In fact, ostarine has been shown in tests to be non suppressive when used at moderate dosages for 4 weeks or less.
Additionally, it has been proven that mk2866 will increase bone mass and will improve joint health. It does this by increasing bone density in the body due to the anabolic effects on skeletal muscle and connective tissues.
Furthermore, ostabolic will not increase estrogen levels, as there is no aromatization with this compound. Neither will it cause dihydrotestosterone (DHT) issues like balding hair, or lead to the metabolization of nortestosterone, which can affect libido and sexual health.
History
Originally, ostarine was under development by Merck, and has since been taken over by GTX, Inc. The end goal of developing mk2866 is to replace growth hormone and hormone replacement therapy, especially with those suffering from old age or muscle wasting diseases.
In the meantime, athletes have acquired ostabolic, and have utilized it to help them reach their fitness goals. Hence the reason it has become extremely widespread in the crossfit community in recent years.
How it Works
Ostabolic does what all SARMS do - it binds and activates the androgen receptors to create a boost in protein synthesis, making muscle and strength gains much easier for the user, and preventing any sort of catabolic effects. Nonetheless, unlike anabolic steroids, it does this without causing prostate issues and shutdown of the pituitary glands. In fact, ostarine has been shown in tests to be non suppressive when used at moderate dosages for 4 weeks or less.
Additionally, it has been proven that mk2866 will increase bone mass and will improve joint health. It does this by increasing bone density in the body due to the anabolic effects on skeletal muscle and connective tissues.
Furthermore, ostabolic will not increase estrogen levels, as there is no aromatization with this compound. Neither will it cause dihydrotestosterone (DHT) issues like balding hair, or lead to the metabolization of nortestosterone, which can affect libido and sexual health.
Last edited: